With cannabis edibles, extracts and topicals legal as of Oct. 17, Sixth Estate’s Spotlight series joined the Canadian Centre for Substance Use and Addiction to discuss with experts and stakeholders the new product classes, health risks, and lower risk use of the products, as well as the importance of public education and best ways to reach out to youth.
As pharmacare was a major election issue, and the re-elected Liberal government has promised to implement a national pharmacare program in accordance with the Hoskins report, Before the Bell assembled a panel of experts and stakeholders to discuss what options the government may be exploring.
Before the Bell returns next Thursday, November 14th to discuss what everyone expects to be a key priority for our next government – a national Pharmacare plan. Guests appearing on Before the Bell include: Dr. Seema Nagpal vice president science and policy with Diabetes Canada, Joelle Walker vice president public affairs, Canadian Pharmacists Association, Dr. Jennifer Shulman partner KPMG,
As cannabis edibles, extracts, and topicals are being legalized, Sixth Estate’s Spotlight hosted a panel of experts to discuss the new risks and regulatory challenges separate from the existing cannabis market, and the public education initiatives underway in the country when it comes to these products.
Edible cannabis products, cannabis extracts and cannabis topicals will be legal on October 17,.
Canadians need the facts to make informed choices about these products
By Dale Smith Whether or not you’re suddenly consuming marijuana as of one second past midnight on October 17th, the legalization of weed in Canada will affect your life. On the eve of cannabis legalization, Sixth Estate’s Spotlight series discussed the ramifications of the change, and what Canadians should realistically expect and prepare for. Host Catherine
By Dale Smith A 2015 poll shows that 91 percent of Canadians support implementing a universal pharmacare program, which is likely to make this a topic that will be grabbing attention during next year’s federal election. Before the Bellhosted a panel of experts to discuss the options currently under discussion, the costs involved, and the
By Pamela Fralick, President, Innovative Medicines Canada It has often been cited that Canada is the only major western country with a national Medicare system that does not include some version of a national public drug plan. Last year, more than 620 million prescriptions were filled by Canadians. Pharmaceuticals are the most frequently used therapeutic
While health care systems across Canada are testing innovations to improve care and save costs, they have a hard time getting widespread adoption across the country. Before the Bell spoke with a panel of experts and stakeholders to discuss what where some of the problems with adoption lie, and why it can be so difficult for good ideas to spread throughout the system.
Years of the health systems transformation conversation have led to one resounding conclusion: pretty much everyone agrees things need to change. And we even agree on some changes we need to improve patient experience, population health and work life of health-care providers while containing costs. So why don’t we to make the significant leaps forward